These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 4006395

  • 1. Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage.
    Matzke GR, Kovarik JM, Rybak MJ, Boike SC.
    Clin Pharm; 1985; 4(3):311-5. PubMed ID: 4006395
    [Abstract] [Full Text] [Related]

  • 2. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
    Garrelts JC, Godley PJ, Horton MW, Karboski JA.
    Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
    [Abstract] [Full Text] [Related]

  • 3. Computer dosing program for the initiation of vancomycin therapy.
    Ito MK, Duren LL, Simonian JS, Dreyfus-Vigil SD, Cookson TL.
    Clin Pharm; 1993 Feb; 12(2):126-30. PubMed ID: 8453861
    [Abstract] [Full Text] [Related]

  • 4. [Initial dosage of vancomycin in neutropenic hematologic patients].
    Soto J, Alsar MJ, Sacristán JA.
    Sangre (Barc); 1992 Jun; 37(3):181-4. PubMed ID: 1440095
    [Abstract] [Full Text] [Related]

  • 5. Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks.
    Nakayama H, Echizen H, Tanaka M, Sato M, Orii T.
    Ther Drug Monit; 2008 Feb; 30(1):103-7. PubMed ID: 18223471
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Niioka T, Uno T, Yasui-Furukori N, Takahata T, Shimizu M, Sugawara K, Tateishi T.
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
    [Abstract] [Full Text] [Related]

  • 7. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
    Tanaka A, Suemaru K, Otsuka T, Ido K, Nishimiya T, Sakai I, Hasegawa H, Inoue T, Murase M, Yasukawa M, Araki H.
    Ther Drug Monit; 2007 Apr; 29(2):261-4. PubMed ID: 17417082
    [Abstract] [Full Text] [Related]

  • 8. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F, Uehlinger DE.
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [Abstract] [Full Text] [Related]

  • 9. Individualized adjustment of vancomycin dosage: comparison with two dosage nomograms.
    Rybak MJ, Boike SC.
    Drug Intell Clin Pharm; 1986 Jan; 20(1):64-8. PubMed ID: 3943460
    [Abstract] [Full Text] [Related]

  • 10. Correlation of predicted versus measured creatinine clearance values in burn patients.
    Lott RS, Uden DL, Wargin WA, Strate RG, Zaske DE.
    Am J Hosp Pharm; 1978 Jun; 35(6):717-20. PubMed ID: 665687
    [Abstract] [Full Text] [Related]

  • 11. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J, Tutor JC.
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D, Atanasova I, Dimitrova V, Robeva R, Unger S, Mück W.
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [Abstract] [Full Text] [Related]

  • 13. Correlation coefficient versus prediction error in assessing the accuracy of digoxin dosing methods.
    Lalonde RL, Pao D.
    Clin Pharm; 1984 Aug; 3(2):178-83. PubMed ID: 6723224
    [Abstract] [Full Text] [Related]

  • 14. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME, Lipman J, Tett SE.
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [Abstract] [Full Text] [Related]

  • 15. Vancomycin pharmacokinetics in middle-aged and elderly men.
    Leonard AE, Boro MS.
    Am J Hosp Pharm; 1994 Mar 15; 51(6):798-800. PubMed ID: 8010319
    [Abstract] [Full Text] [Related]

  • 16. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
    Leader WG, Tsubaki T, Chandler MH.
    Am J Hosp Pharm; 1994 Sep 01; 51(17):2125-30. PubMed ID: 7985687
    [Abstract] [Full Text] [Related]

  • 17. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH.
    Clin Ther; 2007 Jun 01; 29(6):1107-15. PubMed ID: 17692725
    [Abstract] [Full Text] [Related]

  • 18. Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit.
    Snider RD, Kruse JA, Bander JJ, Dunn GH.
    Pharmacotherapy; 1995 Jun 01; 15(6):747-53. PubMed ID: 8602383
    [Abstract] [Full Text] [Related]

  • 19. Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.
    Dailly E, Le Floch R, Deslandes G, Pannier M, Jolliet P.
    Int J Antimicrob Agents; 2008 Jun 01; 31(6):537-9. PubMed ID: 18462925
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.
    Moellering RC, Krogstad DJ, Greenblatt DJ.
    Rev Infect Dis; 1981 Jun 01; 3 suppl():S230-5. PubMed ID: 7342286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.